➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Harvard Business School
Merck
AstraZeneca
Mallinckrodt

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: delafloxacin meglumine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

delafloxacin meglumine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Melinta BAXDELA delafloxacin meglumine POWDER;INTRAVENOUS 208611 NDA Melinta Therapeutics, Inc 70842-102-03 10 VIAL, GLASS in 1 CARTON (70842-102-03) > 10.5 mL in 1 VIAL, GLASS (70842-102-01)
Melinta BAXDELA delafloxacin meglumine TABLET;ORAL 208610 NDA Melinta Therapeutics, Inc 70842-101-01 1 BOTTLE in 1 CARTON (70842-101-01) > 20 TABLET in 1 BOTTLE
Melinta BAXDELA delafloxacin meglumine TABLET;ORAL 208610 NDA Melinta Therapeutics, Inc 70842-101-02 2 BLISTER PACK in 1 CARTON (70842-101-02) > 10 TABLET in 1 BLISTER PACK (70842-101-03)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Medtronic
McKinsey
Dow
Harvard Business School